Results 131 to 140 of about 757,181 (341)
Observations on the Anemia of Cryptogenetic Splenomegaly. I. Hemolysis [PDF]
A. J. S. McFadzean, D. Todd, K. C. TSANG
openalex +1 more source
Anti‐ADAMTS13 Antibodies Trajectory is Associated With ADAMTS13 Recovery in Immune‐Mediated TTP
Anti‐ADAMTS13 IgG antibodies titer trajectory from baseline to day 7–14 post‐TPE as a reliable approach to identify iTTP patients at risk of late response to the triplet therapy regimen. ABSTRACT Current triplet regimens associating therapeutic plasma exchange (TPE), immunosuppression with corticosteroids and rituximab, and caplacizumab have ...
Marie Robert+29 more
wiley +1 more source
Hereditary Elliptocytosis Resulting From Heterozygosity for β Spectrin Tandil
American Journal of Hematology, EarlyView.
María‐Angustias Molina‐Arrebola+1 more
wiley +1 more source
ABSTRACT Hereditary hemorrhagic telangiectasia (HHT, Osler‐Weber‐Rendu disease) is the second most common inherited bleeding disorder worldwide, affecting approximately 1 in 5000 people. Development of disease‐modifying and efficacious hemostatic agents to treat HHT has finally begun after decades without such medical therapies.
Hanny Al‐Samkari+22 more
wiley +1 more source
Cardiac Hypertrophy in Rats with Phenylhydrazine Anemia
Tom D. Norman, ROBERT D. MCBROOM
openalex +1 more source
BLOOD DEPLETION TO 296,000 IN PERNICIOUS ANEMIA WITH RECOVERY. [PDF]
WILLARD J. STONE
openalex +1 more source
Luspatercept in Transfusion‐Dependent β‐Thalassemia: The Benefit Is Real, and So Are the Risks
American Journal of Hematology, EarlyView.
Khaled M. Musallam
wiley +1 more source